Dissemination (Meeting Coverage)

Patients still face an increased risk of debilitating rebound illness within 6 months of drug...

Recently, 3 innovative, safe, and effective biologic medicines for neuromyelitis optica spectrum...

Appropriate use of the anti-CD19 B-cell depleting antibody inebilizumab (INEB) in the treatment of...

Health-related toughness is a personality trait that has the potential to mitigate the...

Demyelinating disease that primarily affects the spinal cord and optic nerve, neuromyelitis optica...

Immunosuppressive treatment is a major cause for worry for patients with neuromyelitis optica...

The primary forum for people and medical experts to share their firsthand knowledge of medical...

There was strong proof that a diet low in fermentable oligo-, di-, monosaccharides, and polyols...

For patients with newly diagnosed, IDH1-mutated acute myeloid leukemia (AML), ivosidenib (IVO)...

In patients with hematologic malignancies, the use of Orca-T, a high-precision cell therapy, led...

Tenapanor is a first-in-class, poorly absorbed, small-molecule inhibitor of the intestinal...

Tenapanor is a small-molecule inhibitor of the intestinal sodium/hydrogen exchanger 3 (NHE3) that...

Although sensory testing is a regular part of anorectal manometry (ARM), there is debate regarding...

In patients with acute myeloid leukemia (AML) across several study cohorts, ivosidenib (IVO) +...

In many research studies, the influence of body mass index (BMI) on the prognosis of individuals...

Isocitrate dehydrogenase 1 (IDH1) mutations are oncogenic factors in acute myeloid leukemia (AML),...

Oncohematology (OH) patients are supported by the intensive care unit (ICU). Admission of OH...